Kilitch Drugs Concludes EGM on Subsidiary Divestment and Board Appointments
Kilitch Drugs India Ltd 路 Extra Ordinary General Meeting 路 16 Nov 2026, 8:00 pm
Kilitch Drugs Concludes EGM on Subsidiary Divestment and Board Appointments Kilitch Drugs (India) Limited conducted its Extra-Ordinary General Meeting on 16th Nov'26 via video conferencing to vote on critical corporate restructuring proposals. Key resolutions placed before shareholders included the divestment of the company's entire shareholding in its material subsidiary and the conversion of existing debt, alongside service costs extended to the subsidiary, into equity shares. Additionally, members considered the five-year appointments of Dr. Milind Kishor Madhani and Mr. Gautam Rajan as Non-Executive Independent Directors. Final voting results and the Scrutinizer鈥檚 report will be disclosed separately.
Original exchange filing (PDF)
More announcements from Kilitch Drugs India Ltd
- We are submitting Scrutinizer''s Report for evoting of EGM 路 16 Nov 2026
- Intimation under regulation 30 of the SEBI LODR regulations 2015, corrigendum to the Notice of Extra Ordinary General Meeting 路 13 Nov 2026
- We are submitting herewith the rectification of typo error in the outcome of Board meeting dated 22nd October, 2026 路 13 Nov 2026
- We are submitting herewith the outcome of the Board meeting 路 07 Nov 2026
- Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 07 Nov 2026
- Submitting unaudited financials results for quarter ended 30.09.2026 路 07 Nov 2026
- KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 06 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 06 Nov 2026
